Product Name: Human DEC-205 Antibody (CDX-1401, Research Use)
Catalog Number: NBR-0029
Target Name: DEC-205
Trade Name: CDX-1401
Antibody Drug Description: CDX-1401 is a next-generation, off-the-shelf, cancer vaccine designed to activate the patient's immune system against cancers that express the tumor marker, NY-ESO-1. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: DEC-205
Synonyms: LY75; CLEC13B; CD205
Target Description: Acts as an endocytic receptor to direct captured antigens from the extracellular space to a specialized antigen-processing compartment (By similarity). Causes reduced proliferation of B-lymphocytes.
Ensembl: ENSG00000054219
Uniprot: O60449